The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline
Open accessAbstract
Objective: To test the hypothesis that cortical and hippocampal volumes, measured in vivo from volumetric MRI (vMRI) scans, could be used to identify variant subtypes of Alzheimer disease (AD) and to prospectively predict the rate of clinical decline. Methods: Amyloid-positive participants with AD from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) 1 and ADNI2 with baseline MRI scans (n = 229) and 2-year clinical follow-up (n = 100) were included. AD subtypes (hippocampal sparing [HpSpMRI], limbic predominant [LPMRI], typical AD [tADMRI]) were defined according to an algorithm analogous to one recently proposed for tau neuropathology. Relationships between baseline hippocampal volume to cortical volume ratio (HV:CTV) and clinical variables were examined by both continuous regression and categorical models. Results: When participants were divided categorically, the HpSpMRI group showed significantly more AD-like hypometabolism on 18F-fluorodeoxyglucose-PET (p < 0.05) and poorer baseline executive function (p < 0.001). Other baseline clinical measures did not differ across the 3 groups. Participants with HpSpMRI also showed faster subsequent clinical decline than participants with LPMRI on the Alzheimer9s Disease Assessment Scale, 13-Item Subscale (ADAS-Cog13), Mini-Mental State Examination (MMSE), and Functional Assessment Questionnaire (all p < 0.05) and tADMRI on the MMSE and Clinical Dementia Rating Sum of Boxes (CDR-SB) (both p < 0.05). Finally, a larger HV:CTV was associated with poorer baseline executive function and a faster slope of decline in CDR-SB, MMSE, and ADAS-Cog13 score (p < 0.05). These associations were driven mostly by the amount of cortical rather than hippocampal atrophy. Conclusions: AD subtypes with phenotypes consistent with those observed with tau neuropathology can be identified in vivo with vMRI. An increased HV:CTV ratio was predictive of faster clinical decline in participants with AD who were clinically indistinguishable at baseline except for a greater dysexecutive presentation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, patients with LOAD often branch into distinct groups including (i) slow versus rapid cognitive decliners (7), (ii) amnestic versus nonamnestic AD (8), (iii) executive versus cortical visual defect versus dysphasia-predominant AD (9), (iv) psychosis and depression-associated AD (10–12), and (v) metabolic dysfunction–associated AD modulated by abnormalities in insulin resistance, Hormo”
From Molecular subtyping of Alzheimer’s disease using RNA sequencing data reveals novel mechanisms and targets (2021) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Self-citationMurray, M. E., Graff-Radford, N. R., Ross, O. A., Petersen, R. C., Duara, R., & Dickson, D. W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70156-9 · Cited by 972
Self-citationInitiative, A. D. N., Crane, P. K., Carle, A. C., Gibbons, L. E., Insel, P. S., Mackin, R. S., Gross, A. L., Jones, R. N., Mukherjee, S., Curtis, S. M., et al. (2012) · Brain Imaging and Behavior · doi:10.1007/s11682-012-9186-z · Cited by 647
Self-citationThe Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
Weiner, M. W., Aisen, P. S. S., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Shaw, L. M. J., Saykin, A. J., Morris, J. C., Cairns, N. J., Beckett, L. A., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.007 · Cited by 613
Self-citationInitiative, A. D. N., Gibbons, L. E., Carle, A. C., Mackin, R. S., Harvey, D. J., Mukherjee, S., Insel, P. S., Curtis, S. M., Mungas, D., & Crane, P. K. (2012) · Brain Imaging and Behavior · doi:10.1007/s11682-012-9176-1 · Cited by 511
Self-citationLandau, S. M., Breault, C., Joshi, A. D., Pontecorvo, M. J., Mathis, C. A., Jagust, W. J., & Mintun, M. A. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109009 · Cited by 472
Self-citationThe topography of grey matter involvement in early and late onset Alzheimer's disease
Frisoni, G. B., Pievani, M., Testa, C., Sabattoli, F., Bresciani, L. C., Bonetti, M., Beltramello, A., Hayashi, K. M., Toga, A. W., & Thompson, P. M. (2007) · Brain · doi:10.1093/brain/awl377 · Cited by 444
Self-citationWhitwell, J. L., Dickson, D. W., Murray, M. E., Weigand, S. D., Tosakulwong, N., Senjem, M. L., Knopman, D. S., Boeve, B. F., Parisi, J. E., Petersen, R. C., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70200-4 · Cited by 419
Self-citation
Cited by
Sorted by citations
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
Initiative, T. A. D. N., Vogel, J. W., Young, A. L., Oxtoby, N. P., Smith, R., Ossenkoppele, R., Strandberg, O. T., La Joie, R., Aksman, L. M., Grothe, M. J., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01309-6 · Cited by 741
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Veitch, D. P., Weiner, M. W., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.005 · Cited by 454
Self-citationBiological subtypes of Alzheimer disease
Ferreira, D., Nordberg, A. K., & Westman, E. (2020) · Neurology · doi:10.1212/wnl.0000000000009058 · Cited by 427
Neff, R. A., Wang, M., Vatansever, S., Guo, L., Ming, C., Wang, Q., Wang, E., Horgusluoglu-Moloch, E., Song, W.-M., Li, A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abb5398 · Cited by 306
“For instance, patients with LOAD often branch into distinct groups including (i) slow versus rapid cognitive decliners (7), (ii) amnestic versus nonamnestic AD (8), (iii) executive versus cortical visual defect versus dysphasia-predominant AD (9), (iv) psychosis and depression-associated AD (10–12), and (v) metabolic…”
BackgroundPredicting Alzheimer's disease progression using deep recurrent neural networks
Nguyen, M., He, T., An, L., Alexander, D. C., Feng, J., Yeo, B. T. T., & Initiative, F. T. A. D. N. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117203 · Cited by 231
Self-citationDuara, R., & Barker, W. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01185-z · Cited by 187
Self-citationDisentangling Heterogeneity in Alzheimer’s Disease and Related Dementias Using Data-Driven Methods
Habes, M., Grothe, M. J., Tunc, B., McMillan, C., Wolk, D. A., & Davatzikos, C. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.016 · Cited by 167
Self-citationThe basis of cellular and regional vulnerability in Alzheimer’s disease
Mrdjen, D., Fox, E. J., Bukhari, S. A., Montine, K. S., Bendall, S. C., & Montine, T. J. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02054-4 · Cited by 162
Self-citationAtrophy subtypes in prodromal Alzheimer’s disease are associated with cognitive decline
ten Kate, M., Dicks, E., Visser, P. J., van der Flier, W. M., Teunissen, C. E., Barkhof, F., Scheltens, P., Tijms, B. M., & Initiative, A. D. N. (2018) · Brain · doi:10.1093/brain/awy264 · Cited by 150
Self-citationRecent update on the heterogeneity of the Alzheimer’s disease spectrum
Jellinger, K. A. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02449-2 · Cited by 155
Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
Baek, M. S., Cho, H., Lee, H. S., Lee, J., Ryu, Y. H., & Lyoo, C. H. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00710-6 · Cited by 137
Distinct tau PET patterns in atrophy‐defined subtypes of Alzheimer's disease
Ossenkoppele, R., Lyoo, C. H., Sudre, C. H., van Westen, D., Cho, H., Ryu, Y. H., Choi, J. Y., Smith, R. A., Strandberg, O. T., Palmqvist, S., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.08.201 · Cited by 119
Self-citationHammond, T. C., Xing, X., Wang, C., Ma, D., Nho, K. T., Crane, P. K., Elahi, F. M., Ziegler, D. A., Liang, G., Cheng, Q. S., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-1079-x · Cited by 115
Self-citationData-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
Levin, F., Ferreira, D., Lange, C., Dyrba, M., Westman, E., Buchert, R., Teipel, S. J., Grothe, M. J., & Initiative, F. T. A. D. N. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00785-9 · Cited by 109
Self-citationYang, Z., Nasrallah, I. M., Shou, H., Wen, J., Doshi, J. J., Habes, M., Erus, G., Abdulkadir, A., Resnick, S. M., Albert, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26703-z · Cited by 112
Self-citationMitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis
Weidling, I. W., & Swerdlow, R. H. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113321 · Cited by 104
Self-citationGray Matter Changes in Parkinson’s and Alzheimer’s Disease and Relation to Cognition
Krajčovičová, L., Klobušiaková, P., & Rektorová, I. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-1006-z · Cited by 96
Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent Insights
Villa, C., Lavitrano, M., Salvatore, E., & Combi, R. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030061 · Cited by 94
Mattsson, N., Ossenkoppele, R., Smith, R. A., Strandberg, O. T., Ohlsson, T. G., Jögi, J., Palmqvist, S., Stomrud, E., & Hansson, O. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0403-x · Cited by 90
Neuropathological assessment of the Alzheimer spectrum
Jellinger, K. A. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02232-9 · Cited by 85
Late-life obesity is a protective factor for prodromal Alzheimer’s disease: a longitudinal study
Sun, Z., Initiative, A. D. N., Wang, Z.-T., Sun, F.-R., Shen, X., Xu, W., Ma, Y., Dong, Q., Tan, L., & Yu, J. (2020) · Aging · doi:10.18632/aging.102738 · Cited by 85
Self-citationUnderstanding and predicting the longitudinal course of dementia
Melis, R. J. F., Haaksma, M. L., & Terrera, G. M. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000482 · Cited by 84
Four Distinct Subtypes of Alzheimer’s Disease Based on Resting-State Connectivity Biomarkers
Chen, P., Yao, H., Tijms, B. M., Wang, P., Wang, D., Song, C., Yang, H., Zhang, Z., Zhao, K., Qu, Y., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.06.019 · Cited by 81
Friedberg, J. S., Aytan, N., Cherry, J. D., Xia, W., Standring, O. J., Alvarez, V. E., Nicks, R., Svirsky, S. E., Meng, G., Jun, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-59869-5 · Cited by 82
Ferreira, D., Pereira, J. B., Volpe, G., & Westman, E. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00524 · Cited by 73
Pathobiological Subtypes of Alzheimer Disease
Jellinger, K. A. (2020) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000508625 · Cited by 69
Ferreira, D., Shams, S., Cavallin, L., Viitanen, M. H., Martola, J., Granberg, T., Shams, M., Aspelin, P., Wiberg, M. K., Nordberg, A. K., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.05.028 · Cited by 65
Pillai, J. A., Bonner‐Jackson, A., Bekris, L. M., Safar, J., Bena, J., & Leverenz, J. B. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190519 · Cited by 56
Alzheimer's disease neuroimaging
Whitwell, J. L. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000570 · Cited by 67
Sun, N., Mormino, E. C., Chen, J., Sabuncu, M. R., & Yeo, B. T. T. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116043 · Cited by 47
Structural Imaging in Parkinson’s Disease: New Developments
Prange, S., Météreau, É., & Thobois, S. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0964-5 · Cited by 45
Neuropathology of the Alzheimer's continuum: an update
Jellinger, K. A. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3050 · Cited by 52
Deep Brain Stimulation for Alzheimer’s Disease: Tackling Circuit Dysfunction
Lam, J., Lee, J., Liu, C. Y., Lozano, A. M., & Lee, D. J. (2020) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.13305 · Cited by 44
Zhang, B., Lin, L., & Wu, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201274 · Cited by 40
Avelar‐Pereira, B., Belloy, M. E., O'Hara, R. M., Hosseini, S. M. H., & Initiative, A. D. N. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01886-z · Cited by 42
Self-citationLiu, H., Kim, C., Haldiman, T., Sigurdson, C. J., Nyström, S., Nilsson, K. P. R., Cohen, M. L., Wısnıewskı, T., Hammarström, P., & Safar, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101267 · Cited by 37
Tau Subtypes of Alzheimer’s Disease Determined in vivo Using Flortaucipir PET Imaging
Charil, A., Shcherbinin, S., Southekal, S. S., Devous, M. D., Mintun, M. A., Murray, M. E., Miller, B. B., & Schwarz, A. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190264 · Cited by 37
Self-citationMohanty, R., Mårtensson, G., Poulakis, K., Muehlboeck, J., Rodriguez‐Vieitez, E., Chiotis, K., Grothe, M. J., Nordberg, A. K., Ferreira, D., Westman, E., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa192 · Cited by 39
Self-citationTubi, M. A., Kothapalli, D., Hapenney, M., Feingold, F. W., Mack, W. J., King, K. S., Thompson, P. M., & Braskie, M. N. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.025 · Cited by 38
Self-citationYu, M., Risacher, S. L., Nho, K. T., Wen, Q., Oblak, A. L., Unverzagt, F. W., Apostolova, L. G., Farlow, M. R., Brosch, J. R., Clark, D. G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113691 · Cited by 36
Self-citationBachmann, T., Schroeter, M. L., Chen, K., Reiman, E. M., & Weise, C. M. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103371 · Cited by 34
Self-citationMultiple Subtypes of Alzheimer’s Disease Base on Brain Atrophy Pattern
Zhang, B., Lin, L., Wu, S., & Al-Masqari, Z. (2021) · Brain Sciences · doi:10.3390/brainsci11020278 · Cited by 33
Groot, C., Grothe, M. J., Mukherjee, S., Jelistratova, I., Jansen, I. E., van Loenhoud, A. C., Risacher, S. L., Saykin, A. J., Donald, C. L. M., Mez, J., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102660 · Cited by 31
Self-citationStructural and functional imaging of brains
Liu, Z., Zhu, Y. J., Zhang, L., Jiang, W., Liu, Y., Tang, Q., Cai, X., Li, J., Wang, L., Tao, C.-L., et al. (2022) · Science China Chemistry · doi:10.1007/s11426-022-1408-5 · Cited by 33
Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease
Mohanty, R., Ferreira, D., Frerich, S., Muehlboeck, J., Grothe, M. J., Westman, E., & Initiative, A. D. N. (2022) · Neurology · doi:10.1212/wnl.0000000000200573 · Cited by 32
Self-citationA generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings
Baumeister, H., Vogel, J. W., Insel, P. S., Kleineidam, L., Wolfsgruber, S., Stark, M., Gellersen, H. M., Yakupov, R., Schmid, M. C., Lüsebrink, F., et al. (2024) · Brain · doi:10.1093/brain/awae118 · Cited by 33
Self-citationFerreira, D., Mohanty, R., Murray, M. E., Nordberg, A. K., Kantarci, K., & Westman, E. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01471-z · Cited by 35
Self-citationClinical relevance of brain atrophy subtypes categorization in memory clinics
Planche, V., Bouteloup, V., Mangin, J., Dubois, B., Delrieu, J., Pasquier, F., Blanc, F., Paquet, C., Hanon, O., Gabelle, A., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12231 · Cited by 32
Mohanty, R., Ferreira, D., Nordberg, A. K., Westman, E., & Initiative, T. A. D. N. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01173-1 · Cited by 30
Self-citationTNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer’s Disease
Pillai, J. A., Bebek, G., Khrestian, M., Bena, J., Bergmann, C. C., Bush, W. S., Leverenz, J. B., & Bekris, L. M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.638922 · Cited by 29
Rates of lobar atrophy in asymptomatic MAPT mutation carriers
Chen, Q., Boeve, B. F., Senjem, M., Tosakulwong, N., Lesnick, T. G., Brushaber, D., Dheel, C., Fields, J., Forsberg, L., Gavrilova, R., et al. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.05.010 · Cited by 28
Self-citationNeuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer’s Disease
Colvee-Martin, H., Parra, J. R., Gonzalez, G. A., Barker, W., & Duara, R. (2024) · Diagnostics · doi:10.3390/diagnostics14070704 · Cited by 32
Self-citationDefault mode network tau predicts future clinical decline in atypical early Alzheimer’s disease
Katsumi, Y., Howe, I., Eckbo, R., Wong, B., Quimby, M., Hochberg, D., McGinnis, S. M., Putcha, D., Wolk, D. A., Touroutoglou, A., et al. (2024) · Brain · doi:10.1093/brain/awae327 · Cited by 31
Self-citationCognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns
Crane, P. K., Groot, C., Ossenkoppele, R., Mukherjee, S., Choi, S., Lee, M. K., Scollard, P., Gibbons, L. E., Sanders, R. E., Trittschuh, E. H., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13567 · Cited by 24
Self-citationDementia Prevention in Clinical Practice
Niotis, K., Akiyoshi, K., Carlton, C., & Isaacson, R. (2022) · Seminars in Neurology · doi:10.1055/s-0042-1759580 · Cited by 26
Risacher, S. L., & Apostolova, L. G. (2023) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001248 · Cited by 25
Self-citationKropáčová, S., Mitterová, K., Klobušiaková, P., Brabenec, L., Anderková, Ľ., Elfmarková, N., Balážová, Z., Rektor, I., Grmela, R., Svobodová, L., et al. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02068-y · Cited by 27
Frank, B. E., Ally, M., Tripodis, Y., Puzo, C. J., Labriola, C., Hurley, L., Martin, B. M., Palmisano, J. N., Chan, L., Steinberg, E. G., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200304 · Cited by 26
Self-citationChoi, M., Youn, H., Kim, D., Lee, S., Suh, S., Seong, J., Jeong, H., & Han, C. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220739 · Cited by 23
Gautherot, M., Kuchcinski, G., Bordier, C., Sillaire, A. R., Delbeuck, X., Leroy, M., Leclerc, X., Pruvo, J., Pasquier, F., & Lopes, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.729635 · Cited by 22
Kuchcinski, G., Patin, L., Lopes, R., Leroy, M., Delbeuck, X., Rollin‐Sillaire, A., Lebouvier, T., Wang, Y., Spincemaille, P., Tourdias, T., et al. (2022) · European Radiology · doi:10.1007/s00330-022-09014-9 · Cited by 21
Visually Identified Tau 18 F-MK6240 PET Patterns in Symptomatic Alzheimer’s Disease
Krishnadas, N., Huang, K., Schultz, S. A., Doré, V., Bourgeat, P., Goh, A., Lamb, F., Bozinovski, S., Burnham, S. C., Robertson, J. S., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215558 · Cited by 20
Self-citationHromádková, L., Siddiqi, M. K., Liu, H., & Safar, J. (2022) · Cells · doi:10.3390/cells11192997 · Cited by 19
Dong, H., Guo, L., Yang, H., Zhu, W., Liu, F., Xie, Y., Zhang, Y., Xue, K., Li, Q., Liang, M., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1129051 · Cited by 19
Šimko, P., Pupíková, M., Gajdoš, M., Klobušiaková, P., Vávra, V., Šimo, A., & Rektorová, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-51690-8 · Cited by 20
Disentangling tau and brain atrophy cluster heterogeneity across the Alzheimer's disease continuum
Toledo, J. B., Liu, H., Grothe, M. J., Rashid, T., Launer, L. J., Shaw, L. M. J., Snoussi, H., Heckbert, S. R., Weiner, M. W., Trojanwoski, J. Q., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12305 · Cited by 19
Self-citationHuo, Y., Jing, R., Li, P., Chen, P., Si, J., Liu, G., & Liu, Y. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.05.025 · Cited by 18
Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease
Buckley, R. F. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01026-5 · Cited by 18
Planche, V., Coupé, P., Helmer, C., Goff, M. L., Amieva, H., Tison, F., Dartigues, J., & Catheline, G. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.006 · Cited by 17
A review of neuroimaging-based data-driven approach for Alzheimer’s disease heterogeneity analysis
Liu, L., Sun, S., Kang, W., Wu, S., & Lin, L. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2023-0033 · Cited by 16
Li, C., Rusinek, H., Chen, J., Bokacheva, L., Vedvyas, A., Masurkar, A. V., Haacke, E. M., Wısnıewskı, T., & Ge, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.972282 · Cited by 16
Self-citationPursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models
Gurdon, B., & Kaczorowski, C. C. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105558 · Cited by 16
Li, A., Lian, J., & Vardhanabhuti, V. (2025) · PLOS Digital Health · doi:10.1371/journal.pdig.0000795 · Cited by 22
Functional network collapse in neurodegenerative disease
Brown, J. A., Lee, A. J., Fernhoff, K., Pistone, T., Pasquini, L., Wise, A. B., Staffaroni, A. M., Mandelli, M. L., Lee, S. E., Boxer, A. L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65156-6 · Cited by 22
Self-citationGuo, T., Ding, F., Li, D., Zhang, W., Cao, L., & Liu, Z. (2019) · Applied Sciences · doi:10.3390/app9030398 · Cited by 15
Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
Uretsky, M., Gibbons, L. E., Mukherjee, S., Trittschuh, E. H., Fardo, D. W., Boyle, P. A., Keene, C. D., Saykin, A. J., Crane, P. K., Schneider, J. A., et al. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12201 · Cited by 19
Self-citationSadiq, M. U., Kwak, K., Dayan, E., & Initiative, A. D. N. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00941-1 · Cited by 15
Self-citationKärkkäinen, M., Prakash, M., Zare, M., Tohka, J., & Initiative, A. D. N. (2020) · International Journal of Alzheimer s Disease · doi:10.1155/2020/2142854 · Cited by 15
Self-citationBoon, B. D. C., Labuzan, S. A., Peng, Z., Matchett, B. J., Kouri, N., Hinkle, K. M., Lachner, C., Ross, O. A., Ertekin‐Taner, N., Carter, R. E., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207685 · Cited by 11
Self-citationResolving heterogeneity in Alzheimer's disease based on individualized structural covariance network
Zheng, C., Zhao, W. D., Yang, Z., Tang, D., Feng, M., & Guo, S. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110873 · Cited by 13
Cho, H., Baek, M. S., Lee, H. S., Lee, J., Ryu, Y. H., & Lyoo, C. H. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00685-4 · Cited by 13
Dynamic Amyloid PET: Relationships to 18F-Flortaucipir Tau PET Measures
Raman, F., Fang, Y.-H. D., Grandhi, S., Murchison, C., Kennedy, R., Morris, J. C., Massoumzadeh, P., Benzinger, T. L. S., Roberson, E. D., & McConathy, J. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.254490 · Cited by 12
Self-citationMorar, U., Izquierdo, W., Martin, H., Forouzannezhad, P., Zarafshan, E., Unger, E., Bursac, Z., Cabrerizo, M., Barreto, A. B., Vaillancourt, D. E., et al. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12258 · Cited by 11
Self-citationDuff, K. M., Wan, L., Levine, D. A., Giordani, B., Fowler, N. R., Fagerlin, A., King, J. B., & Hoffman, J. M. (2022) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000524548 · Cited by 11
Comorbid neuropathology and atypical presentation of Alzheimer's disease
Piña‐Escudero, S. D., Joie, R. L., Spina, S., Hwang, J., Miller, Z., Huang, E. J., Grant, H. E., Mundada, N. S., Boxer, A. L., Gorno‐Tempini, M., et al. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12602 · Cited by 10
Self-citationBaseline MRI atrophy predicts 2-year cognitive outcomes in early-onset Alzheimer’s disease
Contador, J., Pérez‐Millan, A., Guillén, N., Tort‐Merino, A., Balasa, M., Falgàs, N., Olives, J., Castellví, M., Borrego‐Écija, S., Bosch, B., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10851-9 · Cited by 10
Nohesara, S., Abdolmaleky, H. M., Thiagalingam, S., & Zhou, J. (2023) · Epigenomics · doi:10.2217/epi-2023-0342 · Cited by 20
Ryu, D.-W., Hong, Y. J., Cho, J. H., Kwak, K., Lee, J. M., Shim, Y. S., Youn, Y. C., & Yang, D. W. (2022) · Brain Imaging and Behavior · doi:10.1007/s11682-022-00678-x · Cited by 10
Sheng, C., Sun, Y., Wang, M., Wang, X., Liu, Y. F., Pang, D., Liu, J., Bi, X., Du, W., Zhao, M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200016 · Cited by 8
The reduction of hippocampal volume in Parkinson’s disease
Říha, P., Brabenec, L., Mareček, R., Rektor, I., & Rektorová, I. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02451-8 · Cited by 9
Multi-pathological contributions toward atrophy patterns in the Alzheimer’s disease continuum
Mohanty, R., Ferreira, D., & Westman, E. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1355695 · Cited by 9
The Adult Neurogenesis Theory of Alzheimer’s Disease
Abbate, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221279 · Cited by 11
Jun, M., Ku, B. U., Kim, K., Lee, K. H., & Kim, J. U. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1307204 · Cited by 8
Mixture Modeling for Identifying Subtypes in Disease Course Mapping
Poulet, P., & Durrleman, S. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-78191-0_44 · Cited by 10
Chen, T., Lee, W., Chen, J., Chang, S.-Y., Lin, C.-F., & Chen, H.-C. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01083-8 · Cited by 8
Characterizing the spatiotemporal variability of Alzheimer's disease pathologyPreprint
Vogel, J. W., Young, A., Oxtoby, N., Smith, R., Ossenkoppele, R., Strandberg, O., Joie, R. L., Aksman, L., Grothe, M., Iturria-Medina, Y., et al. (2020) · medRxiv · doi:10.1101/2020.08.20.20176883 · Cited by 10
Self-citationShand, C., Markiewicz, P. J., Cash, D. M., Alexander, D. C., Donohue, M., Barkhof, F., Oxtoby, N. P., & Initiative, T. A. D. N. (2023) · medRxiv · doi:10.1101/2023.02.07.23285572 · Cited by 10
Self-citationA Multiform Heterogeneity Framework for Alzheimer’s Disease Based on Multimodal Neuroimaging
Zhao, K., Chen, P., Wang, D., Zhou, R., Ma, G., & Liu, Y. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.12.009 · Cited by 6
Brain-clinical biotyping in patients with idiopathic REM sleep behavior disorder
Tang, S., Huang, B., Wang, Y., Liu, Y., Wang, J., Zhou, L. N., Gong, S., Yang, Y., Chan, J. W. Y., Chau, S. W. H., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01012-0 · Cited by 8
Metadata
- Authors
- Risacher, S. L., Anderson, W. H., Charil, A., Castelluccio, P. F., Shcherbinin, S., Saykin, A. J., Schwarz, A. J., Initiative, F. T. A. D. N., Initiative, A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., Toga, A. W., Beckett, L., Green, R. C., Morris, J., Shaw, L. M., Khachaturian, Z., Sorensen, G., Carrillo, M., Kuller, L., Raichle, M., Paul, S., Davies, P., Fillit, H., Hefti, F., Holtzman, D., Mesulam, M. M., Potter, W., Snyder, P., Schwartz, A., Montine, T., Petersen, R., Aisen, P., Thomas, R. G., Donohue, M., Walter, S., Gessert, D., Sather, T., Jiminez, G., Balasubramanian, A. B., Mason, J., Sim, I., Beckett, L., Harvey, D., Donohue, M., Jack, C. R., Bernstein, M., Fox, N., Thompson, P., Schuff, N., DeCArli, C., Borowski, B., Gunter, J., Senjem, M., Vemuri, P., Jones, D., Kantarci, K., Ward, C., Jagust, W., Koeppe, R. A., Foster, N., Reiman, E. M., Chen, K., Mathis, C., Landau, S., Morris, J. C., Cairns, N. J., Householder, E., Taylor-Reinwald, L., Shaw, L. M., Trojanowki, J. Q., Lee, V., Korecka, M., Figurski, M., Toga, A. W., Crawford, K., Neu, S., Saykin, A. J., Foroud, T. M., Potkin, S., Shen, L., Faber, K., Kim, S., Nho, K., Thal, L., National, N. B., Albert, M., Frank, R., Hsiao, J., Kaye, J., Quinn, J., Silbert, L., Lind, B., Carter, R., Dolen, S., Schneider, L. S., Pawluczyk, S., Beccera, M., Teodoro, L., Spann, B. M., Brewer, J., Vanderswag, H., Fleisher, A., Heidebrink, J. L., Lord, J. L., Petersen, R., Mason, S. S., Albers, C. S., Knopman, D., Johnson, K., Doody, R. S., Villanueva-Meyer, J., Chowdhury, M., Rountree, S., Dang, M., Stern, Y., Honig, L. S., Bell, K. L., Ances, B., Morris, J. C., Carroll, M., Creech, M. L., Franklin, E., Mintun, M. A., Schneider, S., Oliver, A., Marson, D., Griffith, R., Clark, D., Geldmacher, D., Brockington, J., Roberson, E., Love, M. N., Grossman, H., Mitsis, E., Shah, R. C., deToledo-Morrell, L., Duara, R., Varon, D., Greig, M. T., Roberts, P., Albert, M., Onyike, C., D’Agostino, D., Kielb, S., Galvin, J. E., Cerbone, B., Michel, C. A., Pogorelec, D. M., Rusinek, H., de Leon, M. J., Glodzik, L., De Santi, S., Doraiswamy, M. P., Petrella, J. R., Borges-Neto, S., Wong, T. Z., Coleman, E., Arnold, S. E., Karlawish, J. H., Wolk, D., Clark, C. M., Smith, C. D., Jicha, G., Hardy, P., Sinha, P., Oates, E., Conrad, G., Lopez, O. L., Oakley, M., Simpson, D. M., Porsteinsson, A. P., Goldstein, B. S., Martin, K., Makino, K. M., Ismail, M. S., Brand, C., Mulnard, R. A., Thai, G., Mc-Adams-Ortiz, C., Womack, K., Mathews, D., Quiceno, M., Levey, A. I., Lah, J. J., Cellar, J. S., Burns, J. M., Swerdlow, R. H., Brooks, W. M., Apostolova, L., Tingus, K., Woo, E., Silverman, D. H. S., Lu, P. H., Bartzokis, G., Graff-Radford, N. R., Parfitt, F., Kendall, T., Johnson, H., Farlow, M. R., Hake, A. M., Matthews, B. R., Brosch, J. R., Herring, S., Hunt, C., van Dyck, C. H., Carson, R. E., MacAvoy, M. G., Varma, P., Chertkow, H., Bergman, H., Hosein, C., Black, S., Stefanovic, B., Caldwell, C., Robin Hsiung, G.-Y., Feldman, H., Mudge, B., Assaly, M., Finger, E., Pasternack, S., Rachisky, I., Trost, D., Kertesz, A., Bernick, C., Munic, D., Mesulam, M.-M., Lipowski, K., Weintraub, S., Bonakdarpour, B., Kerwin, D., Wu, C.-K., Johnson, N., Sadowsky, C., Villena, T., Turner, R. S., Johnson, K., Reynolds, B., Sperling, R. A., Johnson, K. A., Marshall, G., Yesavage, J., Taylor, J. L., Lane, B., Rosen, A., Tinklenberg, J., Sabbagh, M. N., Belden, C. M., Jacobson, S. A., Sirrel, S. A., Kowall, N., Killiany, R., Budson, A. E., Norbash, A., Johnson, P. L., Obisesan, T. O., Wolday, S., Allard, J., Lerner, A., Ogrocki, P., Tatsuoka, C., Fatica, P., Fletcher, E., Maillard, P., Olichney, J., DeCarli, C., Carmichael, O., Kittur, S., Borrie, M., Lee, T.-Y., Bartha, R., Johnson, S., Asthana, S., Carlsson, C. M., Potkin, S. G., Preda, A., Nguyen, D., Tariot, P., Burke, A., Trncic, N., Fleisher, A., Reeder, S., Bates, V., Capote, H., Rainka, M., Scharre, D. W., Kataki, M., Adeli, A., Zimmerman, E. A., Celmins, D., Brown, A. D., Pearlson, G. D., Blank, K., Anderson, K., Flashman, L. A., Seltzer, M., Hynes, M. L., Santulli, R. B., Sink, K. M., Gordineer, L., Williamson, J. D., Garg, P., Watkins, F., Ott, B. R., Querfurth, H., Tremont, G., Salloway, S., Malloy, P., Correia, S., Rosen, H. J., Miller, B. L., Perry, D., Mintzer, J., Spicer, K., Bachman, D., Finger, E., Pasternak, S., Rachinsky, I., Rogers, J., Kertesz, A., Drost, D., Pomara, N., Hernando, R., Sarrael, A., Schultz, S. K., Boles Ponto, L. L., Shim, H., Smith, K. E., Relkin, N., Chaing, G., Lin, M., Ravdin, L., Smith, A., Raj, B. A., & Fargher, K.
- Affiliations
- Eli Lilly (United States) (US)
- ORCID
- Risacher, Shannon L.
- Charil, Arnaud
- Shcherbinin, Sergey
- Schwarz, Adam J.
- Weiner, Michael W.
- Green, Robert C.
- Paul, Steven
- Davies, Peter
- Fillit, Howard
- Hefti, Franz
- Snyder, Peter
- Schwartz, Adam
- Thomas, Ronald G.
- Walter, Sarah
- Balasubramanian, Archana B.
- Harvey, Danielle
- Fox, Nick
- Thompson, Paul
- Vemuri, Prashanthi
- Jones, David
- Kantarci, Kejal
- Koeppe, Robert A.
- Reiman, Eric M.
- Chen, Kewei
- Korecka, Magdalena
- Crawford, Karen
- Foroud, Tatiana M.
- Shen, Li
- Faber, Kelley
- Kim, Sungeun
- Nho, Kwangsik
- Hsiao, John
- Kaye, Jeffrey
- Silbert, Lisa
- Schneider, Lon S.
- Heidebrink, Judith L.
- Lord, Joanne L.
- Knopman, David
- Johnson, Kris
- Stern, Yaakov
- Honig, Lawrence S.
- Bell, Karen L.
- Ances, Beau
- Carroll, Maria
- Franklin, Erin
- Oliver, Angela
- Marson, Daniel
- Clark, David
- Geldmacher, David
- Roberson, Erik
- Love, Marissa Natelson
- Shah, Raj C.
- Duara, Ranjan
- Albert, Marilyn
- D’Agostino, Daniel
- Kielb, Stephanie
- Galvin, James E.
- Cerbone, Brittany
- Rusinek, Henry
- Glodzik, Lidia
- Petrella, Jeffrey R.
- Wong, Terence Z.
- Arnold, Steven E.
- Karlawish, Jason H.
- Wolk, David
- Clark, Christopher M.
- Smith, Charles D.
- Hardy, Peter
- Sinha, Partha
- Porsteinsson, Anton P.
- Ismail, M. Saleem
- Thai, Gaby
- Womack, Kyle
- Quiceno, Mary
- Levey, Allan I.
- Lah, James J.
- Burns, Jeffrey M.
- Swerdlow, Russell H.
- Brooks, William M.
- Apostolova, Liana
- Silverman, Daniel H.S.
- Lu, Po H.
- Johnson, Heather
- Farlow, Martin R.
- Hake, Ann Marie
- Brosch, Jared R.
- Carson, Richard E.
- Chertkow, Howard
- Bergman, Howard
- Stefanovic, Bojana
- Feldman, Howard
- Bernick, Charles
- Bonakdarpour, Borna
- Kerwin, Diana
- Turner, Raymond Scott
- Sperling, Reisa A.
- Johnson, Keith A.
- Marshall, Gad
- Yesavage, Jerome
- Taylor, Joy L.
- Lane, Barton
- Rosen, Allyson
- Sabbagh, Marwan N.
- Belden, Christine M.
- Jacobson, Sandra A.
- Kowall, Neil
- Killiany, Ronald
- Budson, Andrew E.
- Norbash, Alexander
- Obisesan, Thomas O.
- Lerner, Alan
- Tatsuoka, Curtis
- Maillard, Pauline
- Olichney, John
- Carmichael, Owen
- Johnson, Sterling
- Asthana, Sanjay
- Carlsson, Cynthia M.
- Preda, Adrian
- Nguyen, Dana
- Tariot, Pierre
- Burke, Anna
- Scharre, Douglas W.
- Kataki, Maria
- Pearlson, Godfrey D.
- Flashman, Laura A.
- Hynes, Mary L.
- Santulli, Robert B.
- Sink, Kaycee M.
- Williamson, Jeff D.
- Ott, Brian R.
- Tremont, Geoffrey
- Salloway, Stephen
- Correia, Stephen
- Miller, Bruce L.
- Perry, David
- Mintzer, Jacobo
- Bachman, David
- Pasternak, Stephen
- Pomara, Nunzio
- Schultz, Susan K.
- Shim, Hyungsub
- Relkin, Norman
- Ravdin, Lisa
- Smith, Amanda
- Venue
- Neurology
- Published
- 2017-11-21
- Volume
- 89
- Issue
- 21
- Pages
- 2176-2186
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC5696639
- OpenAlex
- W2766047614
- Cited by
- 163
- References
- 33
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 20 · 2023: 15 · 2022: 29 · 2021: 21 · 2020: 24 · 2019: 18 · 2018: 7
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- National Institutes of Health (5u01ag024904-10)
- National Institute on Aging (U01-AG-024904, P30AG010129, P30AG010133, K01AG049050, R01AG054076, U01AG032984, R01AG019771, R44AG049540)
- National Cancer Institute (R01CA129769)
- National Institute of Biomedical Imaging and Bioengineering (P41EB015922)
- U.S. National Library of Medicine (R01LM011360)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- hippocampal sparing, cortical atrophy, hippocampal volume, executive function, FDG-PET hypometabolism, volumetric MRI, cognitive decline
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Atrophy, Brain, Cognition Disorders, Cross-Sectional Studies, Female, Humans, Image Processing, Computer-Assisted, Longitudinal Studies, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Peptide Fragments, Regression Analysis, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review